Your browser doesn't support javascript.
loading
Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV.
Lara-Aguilar, Violeta; Valle-Millares, Daniel; Crespo-Bermejo, Celia; Grande-García, Sergio; Llamas-Adán, Manuel; Cortijo-Alfonso, María Engracia; Martín-Carbonero, Luz; Domínguez, Lourdes; Ryan, Pablo; de Los Santos, Ignacio; Bartolomé-Sánchez, Sofía; Vidal-Alcántara, Erick Joan; Jiménez-Sousa, María Angeles; Fernández-Rodríguez, Amanda; Briz, Verónica.
Affiliation
  • Lara-Aguilar V; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Valle-Millares D; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Crespo-Bermejo C; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Grande-García S; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Llamas-Adán M; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Cortijo-Alfonso ME; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Martín-Carbonero L; Internal Medicine Service, La Paz University Hospital (IdiPAZ), Madrid, Spain.
  • Domínguez L; HIV Unit, Internal Medicine Service, Biomedical Research Institute of the Doce de Octubre Hospital (imas12), Madrid, Spain; King's College London University, UK.
  • Ryan P; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Institute of Health Carlos III, Madrid, Spain; Department of Infectious Diseases, HIV/Hepatitis Internal Medicine Service, Infanta Leonor University Hospital, Madrid, Spain.
  • de Los Santos I; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Institute of Health Carlos III, Madrid, Spain; Department of Internal Medicine-Infectious Diseases, Hospital Universitario de La Princesa, Madrid, Spain.
  • Bartolomé-Sánchez S; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Vidal-Alcántara EJ; Pneumococcus Unit, Vaccine-Preventable Bacterial Infections, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Jiménez-Sousa MA; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Institute of Health Carlos III, Madrid, Spain; Viral Infection and Immunity Unit, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
  • Fernández-Rodríguez A; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Institute of Health Carlos III, Madrid, Spain; Viral Infection and Immunity Unit, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain. Electronic address: amandafr@isciii.es.
  • Briz V; Viral Hepatitis Reference and Research Laboratory, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain. Electronic address: veronica.briz@isciii.es.
Biomed Pharmacother ; 162: 114664, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37031491
BACKGROUND: We identified that acute or chronic Hepatitis C (HCV) infection in people living with HIV (PLWHIV) results in different senescence profiles. However, variations in these profiles after HCV elimination, spontaneously or with direct-acting antivirals (DAAs), remain unclear. METHODS: Longitudinal observational study (48 weeks) in 70 PLWHIV: 23 PLWHIV with active HCV-chronic infection (CHC) before and after HCV eradication with DAAs, 12 PLWHIV who spontaneously clarify the HCV (SC), and 35 controls (HIV). Oxidative stress was quantified at DNA, lipid, protein, and nitrate levels, as well as the antioxidant capacity and glutathione enzyme. The replicative senescence was evaluated by relative telomere length measurement by PCR and twenty-six factors related to Senescence-Associated Secretory Phenotype (SASP) were characterized by Luminex. Differences in senescence markers was evaluated by generalized linear models. RESULTS: During follow-up, the SC group achieved a significant improvement in glutathione enzyme and lipid peroxidation. The secretion of SASP markers increased but was still lower than that of the HIV group. Overall, the CHC group reduced the levels of oxidative stress and SASP markers to levels like those of the HIV group. No significant differences in telomere shortening were observed between groups. CONCLUSIONS: As the time since spontaneous resolution of HCV infection increased, patients had an improved senescence profile compared to the HIV group. Elimination of chronic HCV infection by DAAs led to a partial improvement of the senescent profile by restoring oxidative stress levels. However, although some SASP markers reached levels like those of the HIV group, others remained altered.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Hepatitis C / Hepatitis C, Chronic Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: España Country of publication: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Hepatitis C / Hepatitis C, Chronic Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: España Country of publication: Francia